Marta Aliprandi - Publications

Novel PET tracers to distinguish the nature of residual masses after the completion of chemotherapy in metastatic testicular germ cell tumours: A systematic review.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 20, 2026

Dynamic evaluation of the glycolytic determinants LDH-A and GLUT-1 enhances prognostic significance and their inhibition affects the growth of mesothelioma spheroids.

Journal: Molecular metabolism

Published: January 19, 2026

Correction: Cecchi et al. Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions. Cancers 2025, 17, 3199.

Journal: Cancers

Published: December 05, 2025

Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions.

Journal: Cancers

Published: September 09, 2025

NOTCH and PTP4A3 alterations emerge as novel predictive biomarkers and potential therapeutic targets in pleural mesothelioma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: September 21, 2024

New target therapies in prostate cancer: from radioligand therapy, to PARP-inhibitors and immunotherapy.

Journal: The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...

Published: June 11, 2024

Thymic Epithelial Tumor and Immune System: The Role of Immunotherapy.

Journal: Cancers

Published: October 03, 2023

Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs.

Journal: Frontiers in immunology

Published: September 03, 2023

Immunotherapy with immune checkpoint inhibitors and predictive biomarkers in malignant mesothelioma: Work still in progress.

Journal: Frontiers in immunology

Published: December 11, 2022